Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,408 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
Locations
  • Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
  • University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
  • Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
View all 121 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT06973187

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • Kaiser Permanente Southern California Irvine, California, United States
  • University of California San Diego (Ucsd) Moores Cancer Center La Jolla, California, United States
View all 197 locations
View Trial Details
Recruiting

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

NCT06764238

Conditions
Acute Lymphoblastic Leukemia ALL, B Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, +21 more
Locations
  • Anhui Medical University Second Affiliated Hospital Hefei, Anhui, China
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangzhou Women and Children's Medical Center Guangzhou, Guangdong, China
View all 27 locations
View Trial Details
Recruiting

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

NCT07211958

Conditions
Acute Myeloid Leukemias, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Clinical Trial Site Melbourne, Victoria, Australia
  • Clinical Trial Site Nedlands, Western Australia, Australia
  • Clinical Trial Site Perth, Western Australia, Australia
  • Clinical Trial Site Gosford, Australia
View all 83 locations
View Trial Details

Related conditions